Epigenetic and transcriptional profiling of triple negative breast cancer

The human HCC1806 cell line is frequently used as a preclinical model for triple negative breast cancer (TNBC). Given that dysregulated epigenetic mechanisms are involved in cancer pathogenesis, emerging therapeutic strategies target chromatin regulators, such as histone deacetylases. A comprehensiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Perreault, Andrea A., Sprunger, Danielle M., Venters, Bryan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2019
Materias:
Data Descriptor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400101/
https://www.ncbi.nlm.nih.gov/pubmed/30835260
http://dx.doi.org/10.1038/sdata.2019.33

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400101/
https://www.ncbi.nlm.nih.gov/pubmed/30835260
http://dx.doi.org/10.1038/sdata.2019.33

Ejemplares similares